Clinical trials: Fecal Immunochemical Test
Colorectal Neoplasm
Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal Cancer
Early detecting and removing of colorectal advanced adenomas can reduce the incidence of colorectal cancer. Because of the less bleeding of advanced adenomas, sensitivities of the common used quantitative fecal immunochemical…
- Trial name
- NCT04856423
- Testing
- The us-qFIT and colonoscopy with pathological examination
- Where
- 6 sites in China
- Volunteers
- 6,000 people
- Sponsor
- Shandong University
Colon Cancer
Colonoscopy Motivation for Patients With Positive Immunochemical Fecal Test
Patients with an immunochemical fecal test positive, have to undergo a colonoscopy. Around 10% doesn't realize the colonoscopy. This study evaluate the impact of a motivational phone call (given by a doctor) to improve…
- Trial name
- Colofit+ (NCT03276091)
- Testing
- Colofit+ intervention
- Where
- France
- Volunteers
- 127 people, healthy volunteers welcome
- Sponsor
- Patricia Soler-Michel
Fecal Immunochemical Test, Colorectal Cancer Screening
Implementation Intention Planning Guide for FIT Colon Cancer Screening
Fecal immunochemical tests (FIT) are a primary method of screening for colorectal cancer (CRC). Implementation intention planning involves encouraging completion or eliminating barriers for the participant to make a plan to…
- Trial name
- NCT07183046
- Testing
- Implementation Intention Guide
- Where
- 5 sites in United States
- Volunteers
- 1,600 people, healthy volunteers welcome
- Sponsor
- Dartmouth-Hitchcock Medical Center
Colorectal Cancer, Screening Uptake of Colonoscopy and FIT
Uptake to Colorectal Cancer Screening in Familial-risk Population
This is a multicenter, controlled, randomized phase III study to compare participation rate with two screening rounds of fecal occult blood test (FIT) versus one-time screening colonoscopy in first degree relatives (FDR) of…
- Trial name
- NCT02567045
- Testing
- annual FIT and colonoscopy in case of a positive test, colonoscopy with sedation
- Where
- 7 sites in Spain
- Volunteers
- 260 people
- Sponsor
- Hospital Universitario de Canarias
Colorectal Cancer
Faecal Immunochemical Test and Urine Volatile Compounds in Adenoma Detection
Bowel cancer can arise from polyps, which can become cancerous. Polyps are little outgrowths within the lining of the bowel (similar to skin warts).
- Trial name
- FASt (NCT04146662)
- Testing
- Faecal immunochemical test
- Where
- United Kingdom
- Volunteers
- 360 people
- Sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
Colorectal Cancer
Increasing Uptake of Bowel Screening
Bowel cancer is the second biggest cancer killer in the UK, accounting for over 16,000 deaths per year. Screening can reduce deaths from bowel cancer if the people invited participate.
- Trial name
- TEMPO (NCT05408169)
- Testing
- Suggested deadline for return of screening test, Planning sheet
- Where
- United Kingdom
- Volunteers
- 40,000 people, healthy volunteers welcome
- Sponsor
- University of Glasgow
Ulcerative Colitis (UC), Fecal Calprotetin
DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis
This multicenter prospective cohort study aims to evaluate whether a >50% decrease or normalization of both quantitative fecal immunochemical test (qFIT) and fecal calprotectin (FC) levels at 2 weeks after starting conventional…
- Conditions
- Ulcerative Colitis (UC), Fecal Calprotetin, FIT, Biomarker
- Trial name
- DYNAMIC-UC (NCT07111273)
- Testing
- FC and FIT TEST at WEEK0 2 4
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Qilu Hospital of Shandong University
Colorectal Cancer, Colorectal Neoplasms
Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening
Early detecting and removing of colorectal advanced adenomas can reduce incidence of colorectal cancer. In order to reduce the incidence of colorectal cancer, improve the early diagnosis of colorectal cancer, the investigators…
- Conditions
- Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenoma
- Trial name
- NCT05200611
- Testing
- Fecal Immunochemical Test
- Where
- 2 sites in China
- Volunteers
- 5,000 people
- Sponsor
- Shandong University
Colorectal Cancer
Accuracy and Predictive Values for Colorectal Cancer of Quantitative FIT in Symptomatic Patients in Primary Care
The aim of this study is to determine accuracy and predictive values for colorectal cancer of a faecal quantitative immunochemical test (FIT) in unselected symptomatic patients presenting in primary care.
- Trial name
- NCT05156307
- Where
- Sweden
- Volunteers
- 2,500 people
- Sponsor
- Region Örebro County
Colorectal Cancer, Colorectal Neoplasm
A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population
to determine screening value of stool-based SDC2 DNA methylation test for advanced colorectal neoplasia in the asymptomatic Chinese community population.
- Conditions
- Colorectal Cancer, Colorectal Neoplasm, Advanced Adenoma, Adenoma
- Trial name
- NCT04786704
- Testing
- Stool-based SDC2 DNA methylation test, quantitative Fecal immunochemical test
- Where
- China
- Volunteers
- 12,106 people, healthy volunteers welcome
- Sponsor
- Changhai Hospital
Colorectal Cancer, Colorectal Adenomatous Polyp
Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
The primary objective is to compare the performance of Stool-based SDC2 DNA Methylation Test and commercially available Fecal Immunochemical Test(FIT) , on the detection rate of advanced adenomatous polyps and colorectal cancer…
- Conditions
- Colorectal Cancer, Colorectal Adenomatous Polyp, Screening
- Trial name
- NCT04221854
- Testing
- Stool-based SDC2 DNA methylation test, Fecal immunochemical test
- Where
- 8 sites in China
- Volunteers
- 50,000 people, healthy volunteers welcome
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
Colorectal Cancer
Usefulness of Fecal Immunochemical Test in Iron Deficiency Anemia (IDAFIT)
Prospective study to test whether the immunochemical fecal occult blood test (FIT) for colorectal cancer (CRC) helps to prioritize patients with iron deficiency anemia for colonoscopy.
- Trial name
- IDAFIT (NCT02792023)
- Testing
- Immunochemical fecal occult blood test, Colonoscopy, Upper endoscopy
- Where
- Spain
- Volunteers
- 550 people
- Sponsor
- Hospital Universitario de Canarias
Colorectal Cancer
Evidence Based Colorectal Cancer Screening for the Uninsured - Sub-study
This is a sub-study nested within a previously initiated clinical study (# NCT01946282) focusing on individuals not previously randomized at baseline to the original interventions.
- Trial name
- NCT02651974
- Testing
- Control condition, Cost condition, Cost/Future condition
- Volunteers
- 8,565 people
- Sponsor
- University of Texas Southwestern Medical Center
Colorectal Neoplasms, Colorectal Cancer Prevention
ULTRA-high-risk Surveillance to Avoid Future Events: the ULTRA-SAFE Trial
The ULTRA-SAFE clinical trial is a prospective, randomized study designed to address the limitations of current "one-size-fits-all" colorectal cancer surveillance guidelines.
- Conditions
- Colorectal Neoplasms, Colorectal Cancer Prevention, Surveillance Colonoscopy
- Trial name
- ULTRA-SAFE (NCT07378930)
- Testing
- Early triage using Fecal immunochemical test
- Where
- 4 sites in Taiwan
- Volunteers
- 940 people
- Sponsor
- National Taiwan University Hospital
Colorectal Cancer
Colonoscopy Outreach for Rural Communities Aim 2
This study aims to test the effectiveness of a remotely-delivered patient navigation program for increasing colonoscopy completion for colorectal cancer screening, among rural populations.
- Trial name
- NCT05453630
- Testing
- Patient Navigation, Usual Care Control
- Where
- United States
- Volunteers
- 527 people, healthy volunteers welcome
- Sponsor
- University of Washington
Colorectal Cancer
mPATH-Cloud for Colorectal Cancer Screening
This study assesses the effectiveness of colorectal cancer (CRC) screening intervention, mobile Patient Technology for Health (mPATH™-Cloud), compared to usual care among subjects who are overdue for CRC screening according to…
- Trial name
- mPATH-Cloud (NCT06441487)
- Testing
- Mobile Health Decision Support, Usual care
- Where
- 2 sites in United States
- Volunteers
- 1,062 people, healthy volunteers welcome
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
Colorectal Cancer, Advanced Adenocarcinoma
Retrospective Analysis of Colorectal Cancer Screening Results
The purpose of this study is to retrospectively analyze colorectal cancer screening data of 40-74 year old population in Shipai Town, Dongguan City.
- Conditions
- Colorectal Cancer, Advanced Adenocarcinoma, Hyperplastic Polyp, Colorectal Neoplasms
- Trial name
- NCT05374369
- Testing
- SDC2 Gene Methylation Test and Q-FIT Test, Colonoscopy and/or pathological examination
- Where
- China
- Volunteers
- 822 people
- Sponsor
- Creative Biosciences (Guangzhou) Co., Ltd.
Colorectal Cancer
Study of In-home Tests for Colorectal Cancer
The objective of this study is to compare the performance characteristics or accuracy of different in-home screening tests for colorectal cancer (fecal occult blood tests), among patients without symptoms of colorectal cancer.
- Trial name
- SIT (NCT01998009)
- Testing
- fecal occult blood tests
- Where
- 2 sites in United States
- Volunteers
- 1,382 people, healthy volunteers welcome
- Sponsor
- Centers for Disease Control and Prevention
Breast Cancer Screening, Colon Cancer Screening
Bundled Cancer Screening and Genetic Services Navigation
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and…
- Conditions
- Breast Cancer Screening, Colon Cancer Screening, Genetics Predisposition
- Trial name
- NCT07228000
- Testing
- Breast cancer screening navigation, Multicancer screening navigation, Usual care genetics referral
- Where
- 2 sites in United States
- Volunteers
- 820 people, healthy volunteers welcome
- Sponsor
- Georgetown University
Helicobacter Pylori Infection, Colorectal Cancer
European Implementation Study on Simultaneous Screening for Gastric and Colorectal Cancers
The EUGastScreen study is designed as a quality implementation study to explore gastric cancer screening strategies within organised cancer screening frameworks.
- Conditions
- Helicobacter Pylori Infection, Colorectal Cancer, Gastric Cancer
- Trial name
- EUGastScreen (NCT07873580)
- Testing
- Fecal sample acquisition for Helicobacter pylori stool antigen test, Upper endoscopy with biopsies, Colonoscopy with biopsies after bowel cleansing
- Volunteers
- 8,000 people, healthy volunteers welcome
- Sponsor
- University of Latvia